Document
false--12-31Q220190001502034P1Y1750000010900000990000096000000.0052400000 0001502034 2019-01-01 2019-06-30 0001502034 2019-07-18 0001502034 2019-06-30 0001502034 2018-12-31 0001502034 2019-04-01 2019-06-30 0001502034 2018-04-01 2018-06-30 0001502034 2018-01-01 2018-06-30 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001502034 us-gaap:CommonStockMember 2018-06-30 0001502034 us-gaap:CommonStockMember 2017-12-31 0001502034 us-gaap:CommonStockMember 2018-12-31 0001502034 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001502034 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001502034 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001502034 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001502034 us-gaap:RetainedEarningsMember 2017-12-31 0001502034 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001502034 2019-01-01 2019-03-31 0001502034 us-gaap:CommonStockMember 2019-03-31 0001502034 us-gaap:TreasuryStockMember 2018-12-31 0001502034 us-gaap:TreasuryStockMember 2018-06-30 0001502034 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001502034 us-gaap:RetainedEarningsMember 2018-06-30 0001502034 us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2019-01-01 0001502034 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001502034 2018-06-30 0001502034 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001502034 us-gaap:RetainedEarningsMember 2019-03-31 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001502034 2018-01-01 2018-03-31 0001502034 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001502034 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001502034 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001502034 2019-03-31 0001502034 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001502034 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001502034 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001502034 us-gaap:RetainedEarningsMember 2019-06-30 0001502034 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001502034 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001502034 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001502034 us-gaap:RetainedEarningsMember 2018-12-31 0001502034 us-gaap:TreasuryStockMember 2019-03-31 0001502034 us-gaap:CommonStockMember 2019-06-30 0001502034 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001502034 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001502034 2018-03-31 0001502034 2017-12-31 0001502034 us-gaap:TreasuryStockMember 2017-12-31 0001502034 us-gaap:TreasuryStockMember 2019-06-30 0001502034 us-gaap:RetainedEarningsMember 2018-03-31 0001502034 us-gaap:CommonStockMember 2018-03-31 0001502034 us-gaap:TreasuryStockMember 2018-03-31 0001502034 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001502034 gnc:TrancheOneMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheOneMember 2018-01-01 2018-06-30 0001502034 gnc:TrancheTwoMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheTwoMember 2018-01-01 2018-06-30 0001502034 gnc:InternationalVitaminCorporationJointVentureMember srt:ScenarioForecastMember us-gaap:SubsequentEventMember 2023-07-01 0001502034 2019-02-01 2019-02-28 0001502034 gnc:JVFrameworkAgreementMember 2019-02-28 0001502034 gnc:InternationalVitaminCorporationJointVentureMember 2019-02-01 2019-02-28 0001502034 gnc:InternationalVitaminCorporationJointVentureMember srt:ScenarioForecastMember us-gaap:SubsequentEventMember 2019-07-01 2023-07-01 0001502034 gnc:InternationalVitaminCorporationMember gnc:InternationalVitaminCorporationJointVentureMember 2019-02-01 2019-02-28 0001502034 us-gaap:AccountingStandardsUpdate201602Member 2019-01-02 2019-01-02 0001502034 gnc:AccountingStandardsUpdate201602RightOfUseAssetImpairmentMember us-gaap:RetainedEarningsMember 2019-01-01 0001502034 us-gaap:IntersegmentEliminationMember gnc:IntersegmentMember gnc:ManufacturingorWholesaleSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:IntersegmentMember gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ManufacturingorWholesaleSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:IntersegmentMember gnc:ManufacturingorWholesaleSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesalePartnerMember gnc:ManufacturingorWholesaleSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ManufacturingorWholesaleSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ManufacturingorWholesaleSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesalePartnerMember gnc:ManufacturingorWholesaleSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ThirdpartyContractManufacturingMember gnc:ManufacturingorWholesaleSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesalePartnerMember gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesalePartnerMember gnc:ManufacturingorWholesaleSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:IntersegmentMember gnc:ManufacturingorWholesaleSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ThirdpartyContractManufacturingMember gnc:ManufacturingorWholesaleSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ThirdpartyContractManufacturingMember gnc:ManufacturingorWholesaleSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ThirdpartyContractManufacturingMember gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 country:US 2018-04-01 2018-06-30 0001502034 us-gaap:NonUsMember 2018-01-01 2018-06-30 0001502034 us-gaap:NonUsMember 2018-04-01 2018-06-30 0001502034 country:US 2019-04-01 2019-06-30 0001502034 us-gaap:NonUsMember 2019-01-01 2019-06-30 0001502034 us-gaap:NonUsMember 2019-04-01 2019-06-30 0001502034 country:US 2019-01-01 2019-06-30 0001502034 country:US 2018-01-01 2018-06-30 0001502034 gnc:GiftCardLiabilityMember 2019-06-30 0001502034 gnc:DeferredFranchiseFeesMember 2019-01-01 2019-06-30 0001502034 gnc:LoyaltyProgramPointsMember 2019-01-01 2019-06-30 0001502034 gnc:GiftCardLiabilityMember 2018-12-31 0001502034 gnc:LoyaltyProgramPointsMember 2018-12-31 0001502034 gnc:GiftCardLiabilityMember 2019-01-01 2019-06-30 0001502034 gnc:DeferredFranchiseFeesMember 2019-06-30 0001502034 gnc:LoyaltyProgramPointsMember 2019-06-30 0001502034 gnc:DeferredFranchiseFeesMember 2018-12-31 0001502034 us-gaap:OperatingSegmentsMember gnc:InternationalSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:InternationalSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:InternationalSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:InternationalSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:InternationalSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:InternationalSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:InternationalSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:InternationalSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:InternationalSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:InternationalSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:InternationalSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:InternationalSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:InternationalSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:InternationalSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:InternationalSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:InternationalSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProteinMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:CooperativeAdvertisingandOtherFranchiseSupportFeesMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HealthandBeautyMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WeightManagementMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:GeneralMerchandiseMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:FoodandDrinkMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HerbsandGreensMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:CooperativeAdvertisingandOtherFranchiseSupportFeesMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HerbsandGreensMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WeightManagementMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WellnessMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProductSalesMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WeightManagementMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HerbsandGreensMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:VitaminsMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProductSalesMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:VitaminsMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:PerformanceSupplementsMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:FoodandDrinkMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HealthandBeautyMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:SubleaseIncomeMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:SubleaseIncomeMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HealthandBeautyMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:VitaminsMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:SubleaseIncomeMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProteinMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:GeneralMerchandiseMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProteinMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WellnessMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WellnessMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HealthandBeautyMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:CooperativeAdvertisingandOtherFranchiseSupportFeesMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:FoodandDrinkMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WeightManagementMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:PerformanceSupplementsMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:SubleaseIncomeMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:PerformanceSupplementsMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProductSalesMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WholesaleSalestoFranchiseesMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:PerformanceSupplementsMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProteinMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:GeneralMerchandiseMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:FoodandDrinkMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:ProductSalesMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:WellnessMember gnc:UnitedStatesandCanadaSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:GeneralMerchandiseMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:CooperativeAdvertisingandOtherFranchiseSupportFeesMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:HerbsandGreensMember gnc:UnitedStatesandCanadaSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:VitaminsMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:UnitedStatesandCanadaSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:RoyaltyRevenueAndFranchiseFeesMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember gnc:OtherRevenueMember gnc:UnitedStatesandCanadaSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-03-01 0001502034 us-gaap:LetterOfCreditMember gnc:DebtInstrumentLienRatioPeriodThreeMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001502034 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:TermLoanFacilityDueMarchTwoThousandNineteenMember us-gaap:AssetBackedSecuritiesMember 2018-02-28 2018-02-28 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-02-28 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-28 2018-02-28 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2019-06-30 0001502034 gnc:ReducedRateMember gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2018-01-01 2018-12-31 0001502034 us-gaap:RevolvingCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001502034 us-gaap:InterestRateSwapMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheTwoMember srt:MinimumMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember us-gaap:PrimeMember 2018-02-28 2018-02-28 0001502034 gnc:FILOAssetbasedTermLoanFacilityMember 2018-04-01 2018-06-30 0001502034 gnc:InterestRateSwapTwoMember 2018-06-13 0001502034 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001502034 us-gaap:PreferredStockMember gnc:SecuritiesPurchaseAgreementAmendmentInitialIssuanceMember 2018-11-01 2018-11-30 0001502034 gnc:InterestRateSwapOneMember 2018-06-13 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2019-06-30 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2018-02-28 0001502034 gnc:HarbinPharmaceuticalGroupHoldingsCo.Ltd.Member 2019-01-01 2019-03-31 0001502034 us-gaap:LetterOfCreditMember gnc:TrancheOneMember gnc:TermLoanFacilityDueMarchTwoThousandNineteenMember us-gaap:AssetBackedSecuritiesMember 2018-02-28 2018-02-28 0001502034 gnc:InterestRateSwapOneMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:TermLoanFacilityDueMarchTwoThousandNineteenMember us-gaap:AssetBackedSecuritiesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-28 2018-02-28 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 us-gaap:RevolvingCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-02-28 0001502034 gnc:InterestRateSwapTwoMember 2019-06-30 0001502034 us-gaap:InterestRateSwapMember 2018-06-13 0001502034 gnc:InternationalVitaminCorporationJointVentureMember 2019-01-01 2019-03-31 0001502034 us-gaap:RevolvingCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-02-28 0001502034 srt:ScenarioForecastMember gnc:InterestRateSwapTwoMember 2020-06-30 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2019-04-01 2019-06-30 0001502034 gnc:TrancheTwoMember srt:ScenarioForecastMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2019-01-01 2019-12-31 0001502034 srt:MinimumMember gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-28 2018-02-28 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember us-gaap:PrimeMember 2018-02-28 2018-02-28 0001502034 gnc:ReducedRateMember gnc:TrancheTwoMember srt:MaximumMember srt:ScenarioForecastMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2019-01-01 2019-12-31 0001502034 us-gaap:LetterOfCreditMember gnc:DebtInstrumentLienRatioPeriodTwoMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001502034 srt:ScenarioForecastMember gnc:InterestRateSwapTwoMember 2020-12-31 0001502034 gnc:InitialRateMember gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2019-01-01 2019-06-30 0001502034 us-gaap:LetterOfCreditMember gnc:DebtInstrumentLienRatioPeriodOneMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:TermLoanFacilityDueMarchTwoThousandNineteenMember us-gaap:SecuredDebtMember 2019-03-01 2019-03-11 0001502034 gnc:TrancheTwoMember srt:MinimumMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-28 2018-02-28 0001502034 gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2018-02-28 2018-02-28 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2019-06-01 2019-06-30 0001502034 gnc:TrancheOneMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 gnc:TrancheTwoMember srt:MaximumMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-28 2018-02-28 0001502034 gnc:InterestRateSwapTwoMember 2019-06-29 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2018-11-30 0001502034 gnc:ReducedRateMember gnc:TrancheTwoMember srt:MinimumMember srt:ScenarioForecastMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2019-01-01 2019-12-31 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-02-28 2018-02-28 0001502034 gnc:ReducedRateMember gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheTwoMember srt:MaximumMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:SecuredDebtMember us-gaap:PrimeMember 2018-02-28 2018-02-28 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2018-12-31 0001502034 us-gaap:RevolvingCreditFacilityMember 2018-01-01 2018-06-30 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2018-01-01 2018-06-30 0001502034 gnc:SeniorCreditFacilityMember 2018-04-01 2018-06-30 0001502034 gnc:SeniorCreditFacilityMember 2018-01-01 2018-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember gnc:SeniorCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-01-01 2019-06-30 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2018-04-01 2018-06-30 0001502034 gnc:TrancheOneMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2019-01-01 2019-06-30 0001502034 gnc:SeniorCreditFacilityMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheOneMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2018-01-01 2018-06-30 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheTwoMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2018-01-01 2018-06-30 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:ConvertibleDebtMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheTwoMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2018-04-01 2018-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember 2018-04-01 2018-06-30 0001502034 gnc:SeniorCreditFacilityMember 2019-04-01 2019-06-30 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-01-01 2018-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember gnc:SeniorCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-04-01 2019-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember 2019-01-01 2019-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember gnc:SeniorCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-04-01 2018-06-30 0001502034 gnc:TrancheTwoMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2019-01-01 2019-06-30 0001502034 gnc:TrancheOneMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2019-04-01 2019-06-30 0001502034 gnc:TrancheOneMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2018-04-01 2018-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember gnc:SeniorCreditFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-01-01 2018-06-30 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2018-04-01 2018-06-30 0001502034 gnc:TermLoanMember gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:AssetBackedSecuritiesMember 2019-04-01 2019-06-30 0001502034 gnc:TrancheTwoMember gnc:SeniorCreditFacilityMember us-gaap:SecuredDebtMember 2019-04-01 2019-06-30 0001502034 us-gaap:RevolvingCreditFacilityMember 2019-04-01 2019-06-30 0001502034 gnc:InterestRateSwapTwoMember 2018-12-31 0001502034 gnc:InterestRateSwapOneMember 2018-12-31 0001502034 gnc:TrancheOneMember gnc:TermLoanFacilityDueMarchTwoThousandNineteenMember us-gaap:SecuredDebtMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:TermLoanFacilityDueMarchTwoThousandNineteenMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 us-gaap:RevolvingCreditFacilityMember 2017-01-01 2017-12-31 0001502034 gnc:JVFrameworkAgreementMember 2019-01-01 2019-03-31 0001502034 gnc:NutraManufacturingBusinessMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2019-01-01 2019-06-30 0001502034 gnc:InternationalVitaminCorporationMember gnc:InternationalVitaminCorporationJointVentureMember 2019-04-01 2019-06-30 0001502034 gnc:JVFrameworkAgreementMember 2019-01-01 2019-06-30 0001502034 gnc:InternationalVitaminCorporationJointVentureMember 2019-03-01 2019-03-31 0001502034 gnc:GNCHongKongLimitedMember gnc:JVFrameworkAgreementMember 2019-02-28 0001502034 gnc:GNCHongKongLimitedMember gnc:JVFrameworkAgreementMember 2019-03-31 0001502034 gnc:InternationalVitaminCorporationMember gnc:InternationalVitaminCorporationJointVentureMember 2019-06-30 0001502034 gnc:JVFrameworkAgreementMember 2019-06-30 0001502034 gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 gnc:ChinaBusinessMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2019-01-01 2019-03-31 0001502034 gnc:InternationalVitaminCorporationJointVentureCapitalContributionMember 2019-03-01 2019-03-31 0001502034 gnc:InternationalVitaminCorporationJointVentureMember 2019-04-01 2019-06-30 0001502034 gnc:InternationalVitaminCorporationJointVentureCapitalContributionMember 2019-06-30 0001502034 gnc:InternationalVitaminCorporationJointVentureMember 2019-06-30 0001502034 gnc:GNCHongKongLimitedAndInternationalVitaminCorporationMember 2019-06-30 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ForwardContractsMember 2018-12-31 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ForwardContractsMember 2019-06-30 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ForwardContractsMember 2018-12-31 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-06-30 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2019-06-30 0001502034 gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2019-06-30 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:InterestRateSwapMember 2018-12-31 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:InterestRateSwapMember 2019-06-30 0001502034 gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001502034 gnc:TrancheOneMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ForwardContractsMember 2019-06-30 0001502034 gnc:FILOAssetbasedTermLoanFacilityMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:InterestRateSwapMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2018-12-31 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001502034 gnc:TrancheTwoMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2019-06-30 0001502034 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:InterestRateSwapMember 2018-12-31 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001502034 gnc:OnePointFivePercentConvertibleSeniorNotesDueTwentyTwentyMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-06-30 0001502034 gnc:TrancheOneMember gnc:AmendedTermLoanFacilityDueMarchTwoThousandTwentyOneMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2019-06-30 0001502034 gnc:WarehousesVehiclesAndOtherEquipmentMember 2018-12-31 0001502034 gnc:CompanyOwnedFranchiseStoresMember 2018-12-31 0001502034 gnc:CompanyOwnedFranchiseStoresMember 2019-06-30 0001502034 gnc:WarehousesVehiclesAndOtherEquipmentMember 2019-06-30 0001502034 gnc:JVFrameworkAgreementMember 2019-03-01 0001502034 srt:MaximumMember 2019-01-01 2019-06-30 0001502034 gnc:CompanyOwnedFranchiseStoresMember 2019-01-01 2019-06-30 0001502034 gnc:WarehousesVehiclesAndOtherEquipmentMember 2019-04-01 2019-06-30 0001502034 gnc:WarehousesVehiclesAndOtherEquipmentMember 2019-01-01 2019-06-30 0001502034 gnc:CompanyOwnedFranchiseStoresMember 2019-04-01 2019-06-30 0001502034 srt:MinimumMember 2019-01-01 2019-06-30 0001502034 gnc:ViolationsofOregonUnlawfulTradePracticesActMember 2019-06-30 0001502034 gnc:DMAAClaimsMember us-gaap:DamagesFromProductDefectsMember 2019-06-30 0001502034 us-gaap:DamagesFromProductDefectsMember 2019-01-01 2019-06-30 0001502034 gnc:ElizabethNaranjoCaliforniaWageandBreakClaimsMember 2012-02-29 2012-02-29 0001502034 gnc:SubpoenaFromDepartmentofJusticeRelatedtoUSPLabsMember 2016-12-01 2016-12-31 0001502034 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2018-02-13 2018-02-13 0001502034 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2018-11-08 2018-11-08 0001502034 gnc:PrivatePlacementInitialIssuanceMember 2018-11-09 2018-11-09 0001502034 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2018-02-13 0001502034 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-06-30 0001502034 gnc:PrivatePlacementFirstSubsequentIssuanceMember 2019-01-02 2019-01-02 0001502034 us-gaap:SeriesAPreferredStockMember 2019-06-30 0001502034 gnc:PrivatePlacementSecondSubsequentIssuanceMember 2019-02-13 2019-02-13 0001502034 us-gaap:RedeemableConvertiblePreferredStockMember 2019-06-30 0001502034 us-gaap:RedeemableConvertiblePreferredStockMember 2019-01-01 2019-06-30 0001502034 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-06-30 0001502034 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-06-30 0001502034 us-gaap:StockCompensationPlanMember 2019-01-01 2019-06-30 0001502034 gnc:PerformanceVestingRestrictedStockAwardsMember 2019-01-01 2019-06-30 0001502034 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-06-30 0001502034 gnc:MarketVestingRestrictedStockAwardsMember 2019-04-01 2019-06-30 0001502034 gnc:PerformanceVestingRestrictedStockAwardsMember 2018-04-01 2018-06-30 0001502034 gnc:MarketVestingRestrictedStockAwardsMember 2018-01-01 2018-06-30 0001502034 gnc:MarketVestingRestrictedStockAwardsMember 2018-04-01 2018-06-30 0001502034 gnc:PerformanceVestingRestrictedStockAwardsMember 2019-04-01 2019-06-30 0001502034 gnc:TimebasedEmployeeStockOptionsAndRestrictedStockMember 2018-01-01 2018-06-30 0001502034 gnc:TimebasedEmployeeStockOptionsAndRestrictedStockMember 2019-01-01 2019-06-30 0001502034 gnc:PerformanceVestingRestrictedStockAwardsMember 2018-01-01 2018-06-30 0001502034 gnc:MarketVestingRestrictedStockAwardsMember 2019-01-01 2019-06-30 0001502034 us-gaap:ConvertiblePreferredStockMember 2018-04-01 2018-06-30 0001502034 us-gaap:ConvertiblePreferredStockMember 2019-04-01 2019-06-30 0001502034 gnc:TimebasedEmployeeStockOptionsAndRestrictedStockMember 2018-04-01 2018-06-30 0001502034 gnc:TimebasedEmployeeStockOptionsAndRestrictedStockMember 2019-04-01 2019-06-30 0001502034 us-gaap:ConvertibleDebtSecuritiesMember 2019-04-01 2019-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:ManufacturingorWholesaleSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:ManufacturingorWholesaleSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-06-30 0001502034 us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember 2018-01-01 2018-06-30 0001502034 us-gaap:CorporateNonSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:CorporateNonSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember 2018-04-01 2018-06-30 0001502034 srt:ReportableLegalEntitiesMember gnc:ManufacturingorWholesaleSegmentMember 2018-01-01 2018-06-30 0001502034 srt:ReportableLegalEntitiesMember gnc:ManufacturingorWholesaleSegmentMember 2019-04-01 2019-06-30 0001502034 us-gaap:IntersegmentEliminationMember 2019-04-01 2019-06-30 0001502034 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:ManufacturingorWholesaleSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:IntersegmentEliminationMember 2018-04-01 2018-06-30 0001502034 srt:ReportableLegalEntitiesMember gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0001502034 srt:ReportableLegalEntitiesMember gnc:ManufacturingorWholesaleSegmentMember 2018-04-01 2018-06-30 0001502034 us-gaap:IntersegmentEliminationMember gnc:ManufacturingorWholesaleSegmentMember 2019-01-01 2019-06-30 0001502034 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-06-30 xbrli:pure gnc:segment iso4217:USD xbrli:shares gnc:interest_rate_swap gnc:country iso4217:USD gnc:joint_ventures xbrli:shares gnc:lawsuit gnc:tranche gnc:action
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
 
(Mark one)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
 
For the quarterly period ended
June 30, 2019
 
 
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
 
For the transition period from                     to                     .
 
Commission File Number:  001-35113
 GNC Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
20-8536244
(State or other jurisdiction of
(I.R.S. Employer
Incorporation or organization)
Identification No.)
 
 
 
300 Sixth Avenue
15222
Pittsburgh,
Pennsylvania
(Zip Code)
(Address of principal executive offices)
 
 
Registrant’s telephone number, including area code:  (412) 288-4600
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Class A common stock, par value $0.001 per share
 
GNC
 
New York Stock Exchange
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                   Yes No
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                             Yes No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act:
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                                                      
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
 
As of July 18, 2019, there were 84,580,537 outstanding shares of Class A common stock, par value $0.001 per share (the “common stock”), of GNC Holdings, Inc.


Table of Contents

TABLE OF CONTENTS
 
 
 
 
 
PAGE
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements
 
GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(unaudited)
(in thousands)
 
June 30, 2019
 
December 31, 2018
Current assets:
 
Cash and cash equivalents
$
95,893


$
67,224

Receivables, net
110,996


127,317

Inventory (Note 4)
405,426


465,572

Forward contracts for the issuance of convertible preferred stock

 
88,942

Prepaid and other current assets
15,746


55,109

Total current assets
628,061

 
804,164

Long-term assets:
 

 
 

Goodwill
79,266


140,764

Brand name
300,720


300,720

Other intangible assets, net
74,128


92,727

Property, plant and equipment, net
91,966


155,095

Right-of-use assets (Note 8)
379,954

 

Equity method investments (Note 6)
99,709

 

Other long-term assets
34,403


34,380

Total long-term assets
1,060,146

 
723,686

Total assets
$
1,688,207

 
$
1,527,850

Current liabilities:
 

 
 

Accounts payable
$
144,726


$
148,782

Current portion of long-term debt (Note 5)


158,756

Current lease liabilities (Note 8)
113,919

 

Deferred revenue and other current liabilities
104,502


120,169

Total current liabilities
363,147

 
427,707

Long-term liabilities:
 

 
 

Long-term debt (Note 5)
854,740


993,566

Deferred income taxes
13,929


39,834

Lease liabilities (Note 8)
373,219

 

Other long-term liabilities
45,629


82,249

Total long-term liabilities
1,287,517

 
1,115,649

Total liabilities
1,650,664

 
1,543,356

Contingencies (Note 9)


 


 
 
 
 
Mezzanine equity:
 
 
 
  Convertible preferred stock (Note 10)
211,395

 
98,804

 
 
 
 
Stockholders’ deficit:
 

 
 

Common stock
130

 
130

Additional paid-in capital
1,010,591


1,007,827

Retained earnings
554,497


613,637

Treasury stock, at cost
(1,725,349
)

(1,725,349
)
Accumulated other comprehensive loss
(13,721
)

(10,555
)
Total stockholders’ deficit
(173,852
)
 
(114,310
)
Total liabilities, mezzanine equity and stockholders’ deficit
$
1,688,207

 
$
1,527,850

 
The accompanying notes are an integral part of the Consolidated Financial Statements.

1

Table of Contents

GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited)
(in thousands, except per share amounts)

 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
Revenue (Note 3)
$
533,997

 
$
617,944

 
$
1,098,760

 
$
1,225,477

Cost of sales, including warehousing, distribution and occupancy
340,253

 
410,209

 
701,925

 
810,868

Gross profit
193,744

 
207,735

 
396,835

 
414,609

Selling, general, and administrative
143,840

 
158,531

 
292,143

 
319,261

Loss on net asset exchange for the formation of the joint ventures (Note 6)
1,779

 

 
21,293

 

Other (income) loss, net
(593
)
 
320

 
(801
)
 
75

Operating income
48,718

 
48,884

 
84,200

 
95,273

Interest expense, net (Note 5)
24,964

 
32,943

 
57,920

 
54,716

Gain on convertible debt repurchase
(3,214
)
 

 
(3,214
)
 

Loss on forward contracts for the issuance of convertible preferred stock

 

 
16,787

 

Loss on debt refinancing

 

 

 
16,740

Income before income taxes
26,968

 
15,941

 
12,707

 
23,817

Income tax expense (Note 13)
13,030

 
2,600

 
14,986

 
4,286

Income (loss) before income from equity method investments
13,938

 
13,341

 
(2,279
)
 
19,531

Income from equity method investments (Note 6)
2,120

 

 
3,075

 

Net income
$
16,058

 
$
13,341

 
$
796

 
$
19,531

Earnings (loss) per share (Note 11):
 

 
 

 
 
 
 
Basic
$
0.13

 
$
0.16

 
$
(0.09
)
 
$
0.23

Diluted
$
0.11

 
$
0.16

 
$
(0.09
)
 
$
0.23

Weighted average common shares outstanding (Note 11):
 

 
 

 
 
 
 
Basic
83,663

 
83,332

 
83,587

 
83,282

Diluted
140,942

 
83,409

 
83,587

 
83,389

 
The accompanying notes are an integral part of the Consolidated Financial Statements.


2

Table of Contents

GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
(unaudited)
(in thousands)
 
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
Net income
$
16,058

 
$
13,341

 
$
796

 
$
19,531

Other comprehensive loss:
 

 
 

 
 
 
 
 Net change in interest rate swaps:
 
 
 
 
 
 
 
Periodic revaluation of interest rate swap, net of tax(1)
(2,830
)
 
(1,290
)
 
(4,295
)
 
(1,290
)
Reclassification adjustment for interest recognized in Consolidated Statement of Operations, net of tax(2)
268

 
128

 
504

 
128

 Net change in unrecognized loss on interest rate swaps, net of tax
(2,562
)
 
(1,162
)
 
(3,791
)
 
(1,162
)
 Foreign currency translation gain (loss)
186

 
(950
)
 
625

 
(1,796
)
Other comprehensive loss
(2,376
)
 
(2,112
)
 
(3,166
)
 
(2,958
)
Comprehensive income (loss)
$
13,682

 
$
11,229

 
$
(2,370
)
 
$
16,573


(1)
Net of tax of $1.3 million and $0.5 million, respectively, for the three months ended June 30, 2019 and 2018, and net of tax of $1.9 million and $0.5 million, respectively, for the six months ended June 30, 2019 and 2018.
(2)
Net of tax of $0.1 million and $0.0 million, respectively, for the three months ended June 30, 2019 and 2018, and net of tax of $0.2 million and $0.0 million, respectively, for the six months ended June 30, 2019 and 2018.
 

The accompanying notes are an integral part of the Consolidated Financial Statements.


3

Table of Contents

GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Stockholders’ Deficit
(unaudited)
(in thousands)

 
Common Stock
 
Treasury Stock
 
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Loss
 
Total
Stockholders’
Deficit
 
Class A
 
 
 
 
 
 
Shares
 
Dollars
 
 
 
 
 
Balance at December 31, 2018
83,886

 
$
130

 
$
(1,725,349
)
 
$
1,007,827

 
$
613,637

 
$
(10,555
)
 
$
(114,310
)
Impact of the adoption of ASC 842

 

 

 

 
(59,936
)
 

 
(59,936
)
Comprehensive income

 

 

 

 
(15,262
)
 
(790
)
 
(16,052
)
Restricted stock awards
121

 

 

 

 

 

 

Minimum tax withholding requirements
(41
)
 

 

 
(120
)
 

 

 
(120
)
Stock-based compensation

 

 

 
1,334

 

 

 
1,334

Balance at March 31, 2019
83,966

 
$
130

 
$
(1,725,349
)
 
$
1,009,041

 
$
538,439

 
$
(11,345
)
 
$
(189,084
)
Comprehensive income

 

 

 

 
16,058

 
(2,376
)
 
13,682

Restricted stock awards
628

 

 

 

 

 

 

Minimum tax withholding requirements
(15
)
 

 

 
(108
)
 

 

 
(108
)
Stock-based compensation

 

 

 
1,658

 

 

 
1,658

Balance at June 30, 2019
84,579

 
$
130

 
$
(1,725,349
)
 
$
1,010,591

 
$
554,497

 
$
(13,721
)
 
$
(173,852
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
83,567

 
$
130

 
$
(1,725,349
)
 
$
1,001,315

 
$
543,814

 
$
(5,831
)
 
$
(185,921
)
Comprehensive income

 

 

 

 
6,190

 
(846
)
 
5,344

Dividend forfeitures on restricted stock

 

 

 

 
42

 

 
42

Restricted stock awards
149

 

 

 

 

 

 

Minimum tax withholding requirements
(54
)
 

 

 
(223
)
 

 

 
(223
)
Stock-based compensation

 

 

 
1,512

 

 

 
1,512

Balance at March 31, 2018
83,662

 
$
130

 
$
(1,725,349
)
 
$
1,002,604

 
$
550,046

 
$
(6,677
)
 
$
(179,246
)
Comprehensive income

 

 

 

 
13,341

 
(2,112
)
 
11,229

Restricted stock awards
229

 

 

 

 

 

 

Minimum tax withholding requirements
(3
)
 

 

 
(3
)
 

 

 
(3
)
Stock-based compensation

 

 

 
1,962

 

 

 
1,962

Balance at June 30, 2018
83,888

 
$
130

 
$
(1,725,349
)
 
$
1,004,563

 
$
563,387

 
$
(8,789
)
 
$
(166,058
)
 
The accompanying notes are an integral part of the Consolidated Financial Statements.


4

Table of Contents

GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(unaudited)
(in thousands)
 
Six months ended June 30,
 
2019
 
2018
Cash flows from operating activities:

Net income
$
796


$
19,531

Adjustments to reconcile net income to net cash provided by operating activities:
 


 

Depreciation and amortization expense
18,704


24,106

Income from equity method investments
(3,075
)
 

Amortization of debt costs
12,364


9,025

Stock-based compensation
2,992


3,474

Loss on forward contracts related to the issuance of convertible preferred stock
16,787



Loss on net asset exchange for the formation of the joint ventures
21,293

 

Gain on convertible notes repurchase
(3,214
)
 

Gains on refranchising
(398
)
 
(208
)
Loss on debt refinancing

 
16,740

Third-party fees associated with refinancing

 
(16,322
)
Changes in assets and liabilities:





(Increase) decrease in receivables
(4,400
)

2,112

Increase in inventory
(706
)

(9,201
)
(Increase) decrease in prepaid and other current assets
874


(3,175
)
Increase in accounts payable
24,886


6,751

Decrease in deferred revenue and accrued liabilities
(6,081
)

(1,017
)
Decrease in net lease liabilities
(18,556
)
 

Other operating activities
3,057


(2,674
)
Net cash provided by operating activities
65,323


49,142

 





Cash flows from investing activities:
 


 

Capital expenditures
(6,460
)

(8,333
)
Refranchising proceeds
1,710


1,175

Store acquisition costs
(190
)

(118
)
Proceeds from net asset exchange
101,000

 

Capital contribution to the newly formed joint ventures
(13,079
)
 

Net cash provided by (used in) investing activities
82,981


(7,276
)
 





Cash flows from financing activities:
 


 

Borrowings under revolving credit facility
22,000


104,000

Payments on revolving credit facility
(22,000
)

(104,000
)
Proceeds from the issuance of convertible preferred stock
199,950

 

Payments on Tranche B-1 Term Loan
(147,312
)
 
(2,275
)
Payments on Tranche B-2 Term Loan
(123,774
)
 
(21,400
)
Payments on convertible notes repurchase
(24,708
)
 

Original issuance discount and revolving credit facility fees
(10,365
)

(35,235
)
Fees associated with the issuance of convertible preferred stock
(12,814
)
 
(226
)
Minimum tax withholding requirements
(228
)

(3,014
)
Net cash used in financing activities
(119,251
)

(62,150
)
 





Effect of exchange rate changes on cash and cash equivalents
(384
)

(364
)
Net increase (decrease) in cash and cash equivalents
28,669


(20,648
)
Beginning balance, cash and cash equivalents
67,224


64,001

Ending balance, cash and cash equivalents
$
95,893


$
43,353

 
The accompanying notes are an integral part of the Consolidated Financial Statements.

5

Table of Contents

GNC HOLDINGS, INC. AND SUBSIDIARIES
Supplemental Cash Flow Information
(unaudited)



 
As of June 30,
 
2019
 
2018
Non-cash investing activities:
(in thousands)
Capital expenditures in current liabilities
$
1,242

 
$
1,120

Non-cash financing activities:
 
 
 
Original issuance discount (Note 5)
$

 
$
13,231


Refer to Note 8, "Leases" for supplemental cash flow information related to the Company's leases.


The accompanying notes are an integral part of the Consolidated Financial Statements.


6

Table of Contents

GNC HOLDINGS, INC. AND SUBSIDIARIES
Condensed Notes to the Unaudited Consolidated Financial Statements

NOTE 1.  NATURE OF BUSINESS
GNC Holdings, Inc., a Delaware corporation (“Holdings,” and collectively with its subsidiaries and, unless the context requires otherwise, its and their respective predecessors, the “Company”), is a global health and wellness brand with a diversified, omni-channel business. The Company's assortment of performance and nutritional supplements, vitamins, herbs and greens, health and beauty, food and drink and other general merchandise features innovative private-label products as well as nationally recognized third-party brands, many of which are exclusive to GNC. 
The Company's operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products through its three reportable segments, U.S. and Canada, International, and Manufacturing / Wholesale (refer to Note 12, "Segments" for more information). Corporate retail store operations are located in the United States, Canada, Puerto Rico and Ireland. In addition, the Company offers products on the internet through GNC.com and third-party websites. Franchise locations exist in the United States and approximately 50 other countries. Additionally, the Company licenses the use of its trademarks and trade names.
In February 2019, the Company entered into two joint ventures with Harbin Pharmaceutical Group Co., Ltd ("Harbin") to operate its e-commerce business in China (the "HK JV") and retail business in China (the "China JV"), which will accelerate its presence and maximize the Company's opportunities for growth in the Chinese supplement market. Under the terms of the agreement, the Company contributed its China business and retained 35% equity interest in the HK JV and China JV. In March 2019, the Company entered into a strategic joint venture with International Vitamin Corporation ("IVC") regarding the Company's manufacturing business (the "Manufacturing JV"), which enables the Company to increase its focus on product innovation while IVC manages manufacturing and integrates with the Company's supply chain thereby driving more efficient usage of capital. Under the terms of the agreement, the Company received $101 million and contributed its Nutra manufacturing and Anderson facility net assets in exchange for an initial 43% equity interest in the Manufacturing JV. Over the next four years, GNC expects to receive an additional $75 million from IVC, adjusted up or down based on the Manufacturing JV's future performance, as IVC’s ownership of the joint venture increases to 100%.
NOTE 2.  BASIS OF PRESENTATION  
The accompanying unaudited Consolidated Financial Statements, which have been prepared in accordance with the applicable rules of the Securities and Exchange Commission ("SEC"), include all adjustments (of a normal and recurring nature) that management considers necessary to fairly state the Company's results of operations, financial position and cash flows. The December 31, 2018 Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). These interim Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Footnotes included in the Company’s audited financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on March 13, 2019 (the "2018 10-K"). Interim results are not necessarily indicative of the results that may be expected for the remainder of the year ending December 31, 2019.
Recently Adopted Accounting Pronouncements

Adoption of the New Lease Standard

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, which requires lessees to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments for all leases with a term greater than 12 months. This standard is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2018 and is required to be applied using a modified retrospective approach. In July 2018, the FASB issued ASU 2018-11, which provides companies with the option to apply the new lease standard either at the beginning of the earliest comparative period presented or in the period of adoption. The Company adopted ASU 2016-02 and its related amendments (collectively known as "ASC 842") during the first quarter of fiscal 2019 electing the optional transition relief amendment that allows for a cumulative-effect adjustment in the period of adoption and did not restate prior periods.  In transitioning to ASC 842, the Company elected to use the practical expedient package available under the guidance for leases that commenced before the effective date and did not elect to use hindsight. The Company has implemented a new lease management and accounting system and updated its processes and internal controls to comply with the new standard.

7

Table of Contents


The Company leases substantially all of its retail stores in the U.S. and Canada segment, including most of the domestic franchise stores that are leased and subleased to franchisees, its distribution centers in the United States and retail stores in Ireland. In addition, the Company has leased office locations and vehicle and equipment leases to support our store and supply chain operations. All of the Company's leases are classified as operating leases.

The Company determines if a contract contains a lease at inception. The lease liabilities are recognized based on the present value of the future minimum lease payments over the term at the commencement date for leases exceeding 12 months. The lease agreements generally contain lease and non-lease components. Non-lease components primarily include payments for maintenance and utilities. The minimum lease payments include only fixed lease components, as well as any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Lease terms may include options to renew when it is reasonably certain that the Company will exercise an option. The Company estimates its incremental borrowing rate, which was estimated to approximate the interest rate on a collateralized basis with similar terms and payments for each lease, using a portfolio approach. The right-of-use assets recognized are initially equal to the lease liability, adjusted for any lease payments made on or before the commencement dates and lease incentives.

The Company recognized lease liabilities of $550.2 million on January 1, 2019. A right-of-use asset of $504.2 million was recognized based on the lease liability, adjusted for the reclassification of deferred rent of $53.3 million and prepaid rent of $7.3 million. Additionally, the Company recognized $79.8 million of right-of-use asset impairment charges related to certain of the Company's stores for which it was previously determined that the carrying value of the stores' assets were not recoverable. The right-of-use asset impairment charges were recorded as a reduction to January 1, 2019 (opening day) retained earnings, net of tax of $19.8 million. The new lease standard has no impact on the timing or classification of the Company's cash flows as reported in the Consolidated Statement of Cash Flows.

The lease liabilities for the operating leases are amortized using the effective interest method. The right-of-use asset is amortized by taking the difference between total rent expense recorded on straight-line basis and the lease liability amortization. When the right-of-use asset for an operating lease is impaired, lease expense is no longer recognized on a straight-line basis. For impaired leases, the Company continues to amortize the lease liability using the same effective interest method as before the impairment charge and the right-of-use asset is amortized on a straight-line basis.

Refer to Note 8 "Leases" for additional information.

Recently Issued Accounting Pronouncements
In August 2018, the FASB issued ASU 2018-15, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-used software. This standard is effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of the new standard to have a material impact on its Consolidated Financial Statements.

8

Table of Contents

NOTE 3.  REVENUE  
Revenue is recognized when obligations under the terms of a contract with the customer are satisfied. Generally, this occurs with the transfer of control of products or services. The Company satisfies performance obligations either over time or at a point in time as discussed in further detail below. Revenue is measured as the amount of consideration expected to be received in exchange for transferring goods or providing services. Applicable sales tax collected concurrent with revenue-producing activities is excluded from revenue.
U.S. and Canada Revenue
The following is a summary of revenue disaggregated by major source in the U.S. and Canada segment:
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
U.S. company-owned product sales: (1)
(in thousands)
   Protein
$
77,160

 
$
87,072

 
$
157,345

 
$
174,742

   Performance supplements
73,083

 
73,100

 
147,824

 
148,716

   Weight management
29,607

 
38,686

 
60,373

 
78,473

   Vitamins
44,936

 
49,495

 
91,944

 
99,866

   Herbs / Greens
15,536

 
16,945

 
31,391

 
33,103

   Wellness
46,370

 
49,680

 
93,515

 
97,381

   Health / Beauty
46,535

 
47,525

 
92,888

 
95,579

   Food / Drink
26,259

 
28,709

 
54,483

 
54,069

   General merchandise
5,519

 
5,878

 
12,318

 
12,940

Total U.S. company-owned product sales
$
365,005

 
$
397,090

 
$
742,081

 
$
794,869

Wholesale sales to franchisees
59,869

 
60,675

 
118,126

 
117,835

Royalties and franchise fees
8,175

 
8,532

 
16,647

 
17,280

Sublease income
10,498

 
11,633

 
21,474

 
23,398

Cooperative advertising and other franchise support fees
4,754

 
5,973

 
9,821

 
11,506

Other (2)
27,759

 
33,414

 
57,067

 
64,843

Total U.S. and Canada revenue
$
476,060

 
$
517,317

 
$
965,216

 
$
1,029,731

(1)
Includes e-commerce sales.
(2)
Includes revenue primarily related to operations in Canada and the loyalty programs, myGNC Rewards and PRO Access, as further discussed below.
International Revenues
The following is a summary of the revenue disaggregated by major source in the International reportable segment:
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
 
(in thousands)
Wholesale sales to franchisees
$
27,019

 
$
27,185

 
$
52,456

 
$
48,945

Royalties and franchise fees
6,332

 
6,576

 
12,319

 
13,197

Other (1)
6,097

 
14,874

 
15,596

 
26,558

Total International revenue
$
39,448

 
$
48,635

 
$
80,371

 
$
88,700

(1)
Includes revenue related to China operations prior to the transfer of the China business to the HK JV and China JV, which was effective February 13, 2019, wholesale sales to the HK JV and China JV, and revenue from company-owned locations in Ireland.

9

Table of Contents

Manufacturing / Wholesale Revenue
The following is a summary of the revenue disaggregated by major source in the Manufacturing / Wholesale reportable segment:
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
 
(in thousands)
Third-party contract manufacturing(1)
$

 
$
30,580

 
$
15,783

 
$
63,302

Intersegment sales(1)

 
65,238

 
35,505

 
129,901

Wholesale partner sales
18,489

 
21,412

 
37,390

 
43,744

Total Manufacturing / Wholesale revenue
$
18,489

 
$
117,230

 
$
88,678

 
$
236,947

(1)
The decrease in third-party contract manufacturing and intersegment sales for the three and six months ended June 30, 2019 compared to the prior year period is due to the transfer of the Nutra manufacturing business to the newly formed Manufacturing JV effective March 1, 2019.
Revenue by Geography
The following is a summary of the revenue by geography:
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
Total revenues by geographic areas(1):
(in thousands)
United States
$
510,762

 
$
579,324

 
$
1,048,805

 
$
1,151,555

Foreign
23,235

 
38,620

 
49,955

 
73,922

Total revenues
$
533,997

 
$
617,944

 
$
1,098,760

 
$
1,225,477


(1)
Geographic areas are defined based on legal entity jurisdiction.
Balances from Contracts with Customers
Contract assets represent amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. As of December 31, 2018, the Company had contract assets of $25.5 million for specialty manufacturing recorded within prepaid and other current assets on the Consolidated Balance Sheet (with a corresponding reduction to inventory at cost). Due to the transfer of the Nutra manufacturing net assets to the Manufacturing JV on March 1, 2019, the Company had no contract assets on the Consolidated Balance Sheet as of June 30, 2019.

Contract liabilities include payments received in advance of performance under the contract, and are realized with the associated revenue recognized under the contract. The Company's PRO Access and loyalty program points are recorded within deferred revenue and other current liabilities on the Consolidated Balance Sheets. Deferred franchise and license fees are recorded within deferred revenue and other current liabilities and other long-term liabilities on the Consolidated Balance Sheets.

The following table presents changes in the Company’s contract liabilities:

10

Table of Contents

 
Six months ended June 30, 2019
 
Balance at Beginning of Period
 
Recognition of revenue included in beginning balance
 
Contract liability, net of revenue, recognized during the period
 
Balance at the End of Period
 
(in thousands)
Deferred franchise and license fees
$
33,464

 
(5,533
)
 
2,247

 
$
30,178

PRO Access and loyalty program points
24,836

 
(18,093
)
 
19,207

 
25,950

Gift card liability
3,416

 
(1,793
)
 
343

 
1,966


As of June 30, 2019, the Company had deferred franchise fees with unsatisfied performance obligations extending throughout 2029 of $30.2 million, of which approximately $6.5 million is expected to be recognized over the next 12 months. The Company has elected to use the practical expedient allowed under the rules of adoption to not disclose the duration of the remaining unsatisfied performance obligations for contracts with an original expected length of one year or less.
NOTE 4.  INVENTORY
The net realizable value of inventory consisted of the following:
 
June 30, 2019
 
December 31, 2018
 
(in thousands)
Finished product ready for sale
$
405,426

 
$
416,113

Work-in-process, bulk product and raw materials(1)

 
46,520

Packaging supplies(1)

 
2,939

Inventory
$
405,426

 
$
465,572

(1)
The decrease in work-in-process, bulk product and raw materials and packaging supplies as of June 30, 2019 compared with December 31, 2018 is due to the transfer of the Nutra manufacturing net assets to the Manufacturing JV effective March 1, 2019.
NOTE 5.  LONG-TERM DEBT / INTEREST EXPENSE
Long-term debt consisted of the following: 
 
June 30,
2019
 
December 31,
2018